市场调查报告书
商品编码
1258820
到 2028 年临床实验室能力验证市场预测——按类型、成分(聚合□链反应、色谱法、其他技术)和地区进行的全球分析Laboratory Proficiency Testing Market Forecasts to 2028 - Global Analysis By Type, Component (Polymerase Chain Reaction, Chromatography and Other Technologies) and By Geography |
根据 Stratistics MRC 的数据,2022 年全球实验室能力验证市场规模将达到 12 亿美元,预计到 2028 年将达到 19 亿美元,预测期内占比 8.3%。以復合年增长率增长
实验室能力测试用于评估非常规实验室在特定测试或测量方面的长期表现。 在实验室能力测试期间,一件或多件人工製品会在附近的参与实验室之间发送。 每个实验室都遵循一组给定的说明来测量工件(例如,环规或一组量块)并将结果传达给管理层。 将每个实验室公布的给定测量结果与该测量的参考值进行比较。 有多种确定参考值的方法。
据世界卫生组织称,全球约有 6 亿人,即约十分之一的人因食用受污染的食物而生病,估计每年有 42 万人死亡。
主要参与者推动的越来越多的新能力验证计划正在推动全球实验室能力验证市场。 此外,由于严格的法规和 COVID-19 大流行导致对诊断实验室的更多关注,实验室能力测试的使用增加正在推动市场扩张。 能力验证确保用于检测 COVID-19 的测试的製造、处理和交付正确,以实现结果的高精度和可靠性。
认可机构越来越多地使用能力测试作为确保参与认可计划的实验室的可靠性的一种机制,这增加了参与实验室的成本压力。 能力验证所需的时间和资源通常与实验室的运营成本相关。 PT 计划的许多阶段都需要投资,包括制定研究计划时、进行大量研究时、处理和运送样本时以及解释和报告时。 如果结果不好,重复测量来纠正坏数据是昂贵的。
全球实验室能力验证市场预计将受到食品和药物管理局等监管机构实施的严格法规的推动,以确保食品和药品的质量。 由于要求严格,全球很多实验室都选择实验室能力验证。 此外,对测试水以检测污染水平及其流动性的需求不断增长,预计将在未来几年推动全球实验室能力测试市场。
不同 PTS 之间的不一致会对实验室实现其预期目标的能力产生不利影响。 这是由于市场和正在考虑的分析程序之间的技术差异。 然而,推动项目差异化的某些财务和监管因素可能会影响整个项目。 因此,了解 PTS 差异的原因并确定加强机构间协调的机会对于实现预期结果至关重要。
COVID-19 的出现对全球数百万人的生活和业务产生了不利影响。 它还对每个国家的经济产生不利影响并阻碍商业活动。 同时,疫情对全球实验室能力验证行业产生了积极影响。 随着诊断实验室越来越受到 COVID-19 的监管,实验室能力测试在全球市场上越来越受欢迎。 能力验证可确保正确地生产、处理和配给用于识别 COVID-19 的测试,以产生高度准确的结果。
据估计,临床诊断领域将经历有利可图的增长。 这是由于復杂的诊断测试的发展和高早期诊断率,通过使用能力验证进行质量控制已成为临床诊断的重要特征。 此外,能力验证可以提高临床诊断的速度、可重复性和准确性。 这个市场的很大一部分与先进诊断测试的发展和早期诊断的需要有关,使得通过使用能力测试进行质量控製成为临床诊断的重要组成部分。
细胞培养部分预计在预测期内以最快的复合年增长率增长,因为它用于诊断血液中是否存在传染性微生物。 这些测试也在製药行业进行,以确认疫苗和基于细胞培养的产品的有效性。 基于细胞培养的产品(如单克隆抗体)的使用增加也增加了细胞培养检测的使用,以最大限度地提高微生物菌株培养的产量。 此类别中可用的能力测试旨在衡量实验室有效性并检查细胞培养物中的污染物和杂质。
由于医疗保健意识的提高和国际认可实验室数量的增加,预计亚太地区在预测期内将占据最大的市场份额。 由于近年来中国和印度等新兴经济体的存在以及外包服务的显着增加,中国和印度已成为实验室能力验证的高增长市场。 韩国也是亚太地区一个不断增长的市场。
由于製药、食品、饮料、水和环境以及化妆品行业的重大突破,预计北美在预测期内的复合年增长率最高。 主要地区权威机构加强了对实验室运营的监管,迫使使用能力测试来确保运营优势。 此外,对可靠实验室质量控制的日益增长的需求以及多家知名能力验证提供商的存在将有助于区域统计数据。
实验室能力验证市场的主要参与者包括:AOAC International、Absolute Standards, Inc.、LGC Limited、Randox Laboratories Ltd.、American Proficiency Institute、NSI Lab Solutions、Merck & Co ., Inc.、Bio-Rad Laboratories, Inc.、Waters Corporation、Weqas、英国 NEQAS、QACS-The Challenge Test Laboratory 和 Trilogy Analytical Laboratory。
2021 年 10 月,Waters Corporation(美国)与 Sartorius AG(德国)合作,为生物工艺专业人员提供直接访问高质量质谱 (MS) 数据的途径,以加快生物製药工艺开发。我们的目标是改进和提高准确性。
2021 年 10 月,沃特世公司(美国)与特拉华大学(美国)合作,开始为生物加工和生物製造开发新的分析解决方案。
2021年6月,LGC Limited作为一个新的业务集团,将为覆盖关键接触点的整个供应链保障解决方案提供智能保障,专注于製造、实验室、原材料和保健品领域。宣布发展
购买此报告的客户将免费获得以下定制之一。
According to Stratistics MRC, the Global Laboratory Proficiency Testing Market is accounted for $1.2 billion in 2022 and is expected to reach $1.9 billion by 2028 growing at a CAGR of 8.3% during the forecast period. Laboratory proficiency testing is used to assess the long-term performance of atypical laboratories for certain tests or measures. One or more artefacts are sent nearby between participating laboratories during the laboratory proficiency test. Each laboratory measures the artefacts (for example, a ring gauge or a set of gauge blocks) in accordance with a given set of instructions and communicates its findings to the administrator. The results announced by each laboratory for a measure are compared to the reference value for that measure. There are various methods for determining the reference value.
According to the WHO, it is projected that approximately 600 million people or around 1 in 10 people globally suffer from illnesses due to eating contaminated food, leading to 420,000 deaths every year.
The growing number of new proficiency testing programmes promoted by key players is driving the global laboratory proficiency testing market. Furthermore, the growing usage of laboratory proficiency testing as a result of stringent regulations, as well as a growing focus on diagnostic laboratories as a result of the COVID-19 pandemic, is boosting market expansion. Proficiency testing ensures that the tests for the detection of the new corona virus are correctly produced, processed, and delivered in order to achieve high precision and confidence in results.
With the increased use of proficiency testing by authorization organisations as a mechanism to ensure the credibility of laboratories participating in accrediting programmes, the cost pressure on participating laboratories is increasing. The time and resources required for proficiency testing are typically related with the operating costs of a laboratory. Investments are required at many stages of PT programmes, such as when creating the programme of study, conducting numerous tests, handling and shipping the samples, and during the interpretation and reporting phase. In the case of poor results, repeated measurements to correct the poor data incur high expenditures.
The global laboratory proficiency testing market is likely to be driven by stringent rules implemented by regulatory authorities such as the Food and Drug Administration to ensure the quality of food and medication goods. Owing to stringent requirements, many laboratories around the world are opting for laboratory proficiency testing. Furthermore, the growing demand for testing water to detect pollution levels and its mobility is expected to propel the global laboratory proficiency testing market forward in the coming years.
The inconsistency of different PTS has a negative impact on laboratories' capacity to reach their desired aims. This is due to the technical differences between the marketplaces and the analytical procedures under consideration. However, certain financial and regulatory factors that drive programming distinctions may have an impact on the entire programme. Understanding the reasons for the disparities in PTS and identifying opportunities for greater harmonisation between schemes are thus crucial for obtaining the desired results.
The emergence of COVID-19 has had a negative impact on the lives and enterprises of millions of people worldwide. It has hampered enterprises by adversely affecting the economies of the countries. The pandemic, on the other hand, has had a beneficial impact on the global laboratory proficiency testing industry. As diagnostic laboratories become more regulated by the COVID-19, laboratory proficiency testing is gaining traction in the global market. Proficiency testing guarantees that test for identifying the novel corona virus are generated, processed, and given correctly to achieve high precision in results.
The clinical diagnostics segment is estimated to have a lucrative growth. This is due to the development of complicated diagnostic tests and the high rate of early diagnosis, which makes quality control through the use of proficiency testing an important feature in clinical diagnostics. Additionally, proficiency testing can increase clinical diagnostics' speed, repeatability, and accuracy. The substantial share of this market is related to the development of sophisticated diagnostic tests and the necessity for early diagnosis, which makes quality control through the use of proficiency testing a vital part of clinical diagnostics.
The cell culture segment is anticipated to witness the fastest CAGR growth during the forecast period, owing to its use in diagnosing the presence of infectious microorganisms in the blood. These tests are also conducted in the pharmaceutical business to check for the benefits of vaccinations and cell culture-based products. The increased use of cell-culture-based products, such as monoclonal antibodies, has increased the use of cell culture assays to maximise production from microbial strain cultures. The proficiency tests available in this category are for measuring laboratory efficacy and checking for contaminants and impurities in cell cultures.
Asia Pacific is projected to hold the largest market share during the forecast period attributable to the increased healthcare awareness and the rising number of laboratories going for international accreditations in the region. Given the existence of rising economies such as China and India, as well as significant increase in outsourcing services in recent years, China and India have emerged as high-growth markets for laboratory proficiency testing. South Korea is another expanding market in the Asia Pacific area.
North America is projected to have the highest CAGR over the forecast period, because of the major breakthroughs in the pharmaceuticals, food, commercial beverages, water & environment, and cosmetics industries. The increasing regulatory limits on laboratory operations, driven by major regional authoritative organisations, have compelled the use of proficiency testing to provide operational superiority. Furthermore, the growing demand for reliable laboratory quality control and the presence of multiple well-known proficiency testing providers will contribute to regional statistics.
Some of the key players profiled in the Laboratory Proficiency Testing Market include: AOAC International, Absolute Standards, Inc., LGC Limited, Randox Laboratories Ltd., American Proficiency Institute, NSI Lab Solutions, Merck & Co., Inc., Bio-Rad Laboratories, Inc., Waters Corporation, Weqas, UK NEQAS, QACS - The Challenge Test Laboratory and Trilogy Analytical Laboratory.
In October 2021, Waters Corporation (US) partnered with the Sartorius AG (Germany) and was aimed to provide bioprocess experts with direct access to high-quality mass spectrometry (MS) data to accelerate the speed and improve the accuracy of biopharmaceutical process development.
In October 2021, Waters Corporation (US) partnered with the University of Delaware (US) to develop new analytical solutions for bioprocessing and biomanufacturing.
In June 2021, LGC Limited announced the development of a new business group to provide intelligent assurance across supply chains assurance solutions covering critical touchpoints, with a focus on the manufacturing, laboratory, ingredients, and nutritional supplements sectors.
All the customers of this report will be entitled to receive one of the following free customization options: